Related search

Outcomes of Chemotherapies and HER2 Directed Therapies in Advanced HER2-mutant Lung Cancers

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2016English

ZW25 Active in HER2-positive Cancers

Cancer Discovery
Oncology
2018English

Endoscopic Submucosal Dissection for Early Gastric Cancers With Uncommon Histology

Clinical Endoscopy
MedicineNuclear MedicineRadiologyImagingGastroenterology
2016English

A Novel Immunomodulatory and Molecularly Targeted Strategy for Refractory Hodgkin’s Lymphoma

Oncotarget
Oncology
2013English

Erratum: Mechanism of MEK Inhibition Determines Efficacy in Mutant KRAS- Versus BRAF-driven Cancers

Nature
Multidisciplinary
2013English

Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Efficacy and Safety of HER2-Targeted Agents for Breast Cancer With HER2-Overexpression: A Network Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Clinical Cases of the Efficacy of Therapy Multikinase Inhibitors of Metastatic Radioid-Refractory Differentiated Thyroid Cancer

Endocrine Surgery
2018English

3) Immune Checkpoint Inhibitors for Gastrointestinal Tract Cancers

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy